K-TAB Side Effects

6762401-6 | Abdominal Distension, Blood Electrolytes Abnormal, Confusional State, Disturbance In Attention, Feeling Abnormal, Incorrect Dose Administered, Lethargy, Nausea, Paraesthesia
on Nov 24, 2009 Female patient from UNITED STATES , weighting 140.1 lb, was diagnosed with hypokalaemia, pain (What is pain?) and was treated with K-tab (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, blood electrolytes abnormal, confusional state, disturbance in attention, feeling abnormal, incorrect dose administered, lethargy, nausea (What is nausea?), paraesthesia. K-tab dosage: . During the same period patient was treated with KLOR CON (View Klor-con Review and Klor-con Label ), VALIUM (View Valium Review and Valium Label ), XANAX (View Xanax Review and Xanax Label ), MAXZIDE (View Maxzide Review and Maxzide Label ), DARVOCET (View Darvocet Review and Darvocet Label ), ADVIL LIQUI GELS (View Advil Liqui-gels Review and Advil Liqui-gels Label ).

6267161-3 | Cystitis
Patient was taking K-tab (View Usage). Patient had the following side effects: cystitis on Dec 17, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 180.2 lb, was diagnosed with blood cholesterol increased, hypertension, depression (What is depression?), back pain (What is back pain?) and. K-tab dosage: . During the same period patient was treated with LOVASTATIN (View Lovastatin Review and Lovastatin Label ), HYTRIN (View Hytrin Review and Hytrin Label ), AMLODIPINE (1 Tab) (View Amlodipine Review and Amlodipine Label ), PROZAC (View Prozac Review and Prozac Label ), LODINE (View Lodine Review and Lodine Label ).

6267157-1 | Abdominal Pain, Decreased Appetite
Adverse event was reported on Nov 10, 2008 by a Female patient taking K-tab (View Usage) (Dosage: ) was diagnosed with sciatica (What is sciatica?) and. Location: UNITED STATES , 80 years of age, weighting 110.1 lb, After K-tab was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), decreased appetite. During the same period patient was treated with EXTRA STRENGTH TYLENOL (View Extra Strength Tylenol Review and Extra Strength Tylenol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), SERTRALINE (View Sertraline Review and Sertraline Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ).

5993358-3 | Ovarian Cancer
on Dec 03, 2008 Female patient from UNITED STATES , weighting 160.1 lb, was diagnosed with cardiac disorder, osteoporosis prophylaxis, vitamin supplementation and was treated with K-tab (View Usage). Patient experienced the following unwanted or unexpected effects: ovarian cancer. K-tab dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), WARFARIN SODIUM (Dosage Varies) (View Warfarin Sodium Review and Warfarin Sodium Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), FOSAVANCE (View Fosavance Review and Fosavance Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).


5308780-8 | Atrial Fibrillation, Atrioventricular Block Complete, Bradycardia, Dyspnoea, Hyperkalaemia, Mean Arterial Pressure Decreased
on Apr 16, 2007 Male patient from UNITED STATES , 73 years of age, was diagnosed with cardiac failure congestive and was treated with K-tab (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), atrioventricular block complete, bradycardia, dyspnoea, hyperkalaemia, mean arterial pressure decreased. K-tab dosage: . During the same period patient was treated with SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), DABIGATRAN ETEXILATE (View Dabigatran Etexilate Review and Dabigatran Etexilate Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

5255895-9 | Abdominal Distension, Abdominal Pain Upper, Asthenia, Bradycardia, Cardio-respiratory Arrest, Chronic Obstructive Pulmonary Disease, Gallbladder Enlargement, Gastrointestinal Haemorrhage, Hypotension
Patient was taking K-tab (View Usage). After K-tab was administered, patient had the following side effects: abdominal distension, abdominal pain upper, asthenia, bradycardia, cardio-respiratory arrest, chronic obstructive pulmonary disease, gallbladder enlargement, gastrointestinal haemorrhage, hypotension on Feb 27, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 157.0 lb, was diagnosed with mineral supplementation, hypertension and. K-tab dosage: . During the same period patient was treated with DABIGATRAN ETEXILATE (View Dabigatran Etexilate Review and Dabigatran Etexilate Label ), DIOVAN (View Diovan Review and Diovan Label ), DILTIAZEM HYDROCHLORIDE (View Diltiazem Hydrochloride Review and Diltiazem Hydrochloride Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ATENOLOL (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

5245554-0 | Abdominal Distension, Abdominal Pain Upper, Asthenia, Bradycardia, Cardio-respiratory Arrest, Chronic Obstructive Pulmonary Disease, Gallbladder Enlargement, Gastrointestinal Haemorrhage, Gastrointestinal Ulcer
Adverse event was reported on Feb 15, 2007 by a Male patient taking K-tab (View Usage) (Dosage: ) was diagnosed with mineral supplementation, hypertension and. Location: UNITED STATES , weighting 157.0 lb, Patient experienced the following unwanted or unexpected effects: abdominal distension, abdominal pain upper, asthenia, bradycardia, cardio-respiratory arrest, chronic obstructive pulmonary disease, gallbladder enlargement, gastrointestinal haemorrhage, gastrointestinal ulcer. During the same period patient was treated with DABIGATRAN ETEXILATE (View Dabigatran Etexilate Review and Dabigatran Etexilate Label ), DIOVAN (View Diovan Review and Diovan Label ), DILTIAZEM HYDROCHLORIDE (View Diltiazem Hydrochloride Review and Diltiazem Hydrochloride Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), ATENOLOL (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

5067659-X |
on Dec 07, 2005 Male patient from UNITED STATES , 72 years of age, weighting 224.4 lb, was diagnosed with hypokalaemia and was treated with K-tab (View Usage). . K-tab dosage: 10 Meq, 3 In 1, Per Oral. During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ATENOLOL (View Atenolol Review and Atenolol Label ).

5067650-3 |
on Jul 29, 2005 Female patient from UNITED STATES , 79 years of age, was treated with K-tab (View Usage). . K-tab dosage: 10 Milliequivalents, 1 In 1 D. During the same period patient was treated with SYNTHROID (50 Mcg, 1 In 1 D) (View Synthroid Review and Synthroid Label ).

4835993-1 | Arteriosclerosis, Diabetes Mellitus Insulin-dependent
Patient was taking K-tab (View Usage). Patient experienced the following unwanted or unexpected effects: arteriosclerosis, diabetes mellitus insulin-dependent on Sep 23, 2005 from UNITED STATES Additional patient health information: Female patient , weighting 221.6 lb, was diagnosed with diuretic effect and. K-tab dosage: .

4633974-4 | Cardiac Arrest
Adverse event was reported on Mar 30, 2005 by a Male patient taking K-tab (View Usage) (Dosage: 10 Milliequivalents, 1 In 1 D, Per Oral) . Location: , 53 years of age, Patient had the following side effects: cardiac arrest (What is cardiac arrest?).